Hogan Lovells advises Maxinutrition on sale to GlaxoSmithKline
Hogan Lovells has advised on the sale of Maxinutrition Holdings to Glaxo Group, a subsidiary of GlaxoSmithKline, for GBP162m. The deal was announced on 13 December and is subject to competition clearance. Maxinutrition is a European sports nutrition company. Hogan Lovells acted for Zef Eisenberg and Paul Hick, the founder
